Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis

Bibliographic Details
Main Authors:	Ansell, B. R. E., Dwyer, D. B., Wood, S. J., Bora, E., Brewer, W. J., Proffitt, T. M., Velakoulis, D., McGorry, P. D., Pantelis, C.
Format:	Online
Language:	English
Published:	Cambridge University Press 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413868/

Similar Items

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
by: Miller, Brian J., et al.
Published: (2011)

Intensive case management for high-risk patients with first-episode psychosis: Service model and outcomes
by: Brewer, W., et al.
Published: (2015)

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
by: Demjaha, Arsime, et al.
Published: (2017)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
by: Bodnar, Michael, et al.
Published: (2016)

Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients
by: Kriisa, Kärt, et al.
Published: (2016)

Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study
by: Whale, Richard, et al.
Published: (2016)

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes
by: Stevenson, J M, et al.
Published: (2016)

Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment
by: McGorry, Patrick D., et al.
Published: (2011)

First-generation antipsychotics: not gone but forgotten
by: Dibben, Claire R. M., et al.
Published: (2016)

Functional neuroimaging in first-episode psychosis
by: Gheorghe, Mihai D., et al.
Published: (2005)

Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
by: Murphy, Brendan P., et al.
Published: (2014)

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study
by: Edwards, J., et al.
Published: (2011)

Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients
by: Nieuwenhuis, Mireille, et al.
Published: (2017)

Early Intervention in Psychosis: Obvious, Effective, Overdue
by: McGorry, Patrick D.
Published: (2015)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia
by: Washida, Kenji, et al.
Published: (2013)

Gender differences in first episode psychotic mania
by: Cotton, Sue M, et al.
Published: (2013)

Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study
by: González-Blanch, César, et al.
Published: (2015)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
by: Parellada, Eduard, et al.
Published: (2012)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
by: Jeong, Hyun-Ghang, et al.
Published: (2013)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
by: Adam, Usman U, et al.
Published: (2014)

Ten year neurocognitive trajectories in first-episode psychosis
by: Barder, Helene E., et al.
Published: (2013)

Identifying persistent negative symptoms in first episode psychosis
by: Hovington, Cindy L, et al.
Published: (2012)

Health beliefs and carer burden in first episode psychosis
by: Patel, Maya, et al.
Published: (2014)

Retrospective study on structural neuroimaging in first-episode psychosis
by: Coentre, Ricardo, et al.
Published: (2016)

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
by: Clark, S R, et al.
Published: (2016)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
by: Marcos Leite Santoro, et al.
Published: (2018-08-01)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
by: Patel, Rashmi, et al.
Published: (2016)

Neighbourhood-level socio-environmental factors and incidence of first episode psychosis by place at onset in rural Ireland: The Cavan–Monaghan First Episode Psychosis Study [CAMFEPS]☆
by: Omer, Sami, et al.
Published: (2014)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
by: Kishimoto, Taishiro, et al.
Published: (2011)

Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
by: Přikryl, Radovan, et al.
Published: (2012)

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
by: Misiak, Błażej, et al.
Published: (2014)

The effect of the environment on symptom dimensions in the first episode of psychosis: a multilevel study
by: Oher, F. J., et al.
Published: (2014)

Hitting the floor: Understanding migration patterns following the first episode of psychosis
by: Kirkbride, James B.
Published: (2014)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis
by: Bousman, C A, et al.
Published: (2013)

Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis
by: Yao, Jeffrey K., et al.
Published: (2013)

Diagnostic change 10 years after a first episode of psychosis
by: Heslin, M., et al.
Published: (2015)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
by: Warikoo, Nisha, et al.
Published: (2014)

Attitudes Towards Antipsychotics Among Patients with Schizophrenia on First- or Second-Generation Medications
by: Karthik, M. S., et al.
Published: (2014)

DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis
by: Mössner, Rainald, et al.
Published: (2009)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
by: Noto, Cristiano, et al.
Published: (2015)